Who invested in Microvascular Therapeutics?
Microvascular Therapeutics's investors include National Institutes of Health, National Cancer Institute (NCI) and National Heart, Lung and Blood Institute.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$4.0Mraised across 1 round since 2023, from 1 source
Source recorded
Microvascular Therapeutics's investors include National Institutes of Health, National Cancer Institute (NCI) and National Heart, Lung and Blood Institute.
Microvascular Therapeutics has raised $4.0M across 1 round since 2023.
Microvascular Therapeutics's most recent round was a Grant of $4.0M in Oct 2023.
Its most recent round, $4.0M in Oct 2023, is also its largest on record.
Microvascular Therapeutics's first round on record, in Oct 2023, was backed by National Institutes of Health, National Cancer Institute (NCI) and National Heart, Lung and Blood Institute.
Microvascular Therapeutics's latest named round is a Grant, in Oct 2023.
Microvascular Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.